DUBLIN–(BUSINESS WIRE)–The “Global Contact Lenses Market, By Modality (Reusable, v/s Disposable), By Design (Spherical, Toric, Multifocal & Others), By Material Type (Silicon Hydrogel, Hydrogel, Others), By Application, By Distribution Channel, B…
Category: Business
Global Phenylephrine Hydrochloride Market Insights (2021 to 2026) – Key Analysis and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Phenylephrine Hydrochloride Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type” report has been added to ResearchAndMarkets.com’s offering. This rep…
Global Optical Sorter Market (2021 to 2026) – Growth, Trends, COVID-19 Impact and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Sorter Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering. The optical sorter market is expected to register a CAGR of 10% over the for…
Haymarket Medical Network Launches Optometry Advisor
NEW YORK–(BUSINESS WIRE)–Haymarket Medical Network today launched Optometry Advisor, a new digital resource that empowers primary eye care physicians with comprehensive clinical, refractive, and pharmaceutical information. OptometryAdvisor.com meets …
GenSight Biologics annonce l’octroi par la FDA de la désignation Fast Track pour GS030 comme traitement optogénétique de la rétinopathie pigmentaire
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, éligible PEA-PME), une société biopharmaceutique dédiée au développement et à la commercialisation des thérapies géniques innovantes pour le traitement de…
GenSight Biologics Announces FDA Grant of Fast Track Designation for Optogenetic Therapy GS030 as Treatment for Retinitis Pigmentosa
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
RxCell Inc., A*STAR’s IMCB, NUS, and SERI Collaborate to Develop Cellular Therapeutics for Age-related Diseases
SAN FRANCISCO–(BUSINESS WIRE)–RxCell, a Bay Area-based biotechnology company focused on therapeutic applications of induced pluripotent stem cells (iPSC), together with the Agency for Science, Technology and Research (A*STAR)’s Institute of Molecular…
The Worldwide Automated Optical Inspection Industry is Expected to Reach $1.6+ Billion by 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Automated Optical Inspection Market with COVID-19 Impact Analysis by Type (2D AOI, 3D AOI), Technology (Inline AOI, Offline AOI), Industry, Application (Fabrication Phase, Assembly Phase), Elements of AOI, and Regio…
BVI宣佈投資Beyeonics Vision並展開合作
麻薩諸塞州沃爾瑟姆–(BUSINESS WIRE)–(美國商業資訊)–專業多元化的全球性眼科器材公司BVI今天宣佈，對Elbit Systems Ltd.（NASDAQ: ESLT和TASE: ESLT，簡稱“Elbit Systems”）旗下的醫療科技子公司Beyeonics Vision進行投資。Beyeonics Vision利用整合式擴增實境、追蹤和影像處理/人工智慧平臺，為手術中外科醫生的決策過程提供改進的視覺化、最佳化的工作流程和即時支援。此次合作還促使Beyeonics™ One…
BVI宣布投资Beyeonics Vision并与之开展合作
马萨诸塞州沃尔瑟姆–(BUSINESS WIRE)–(美国商业资讯)–专业多元化眼科器械跨国公司BVI今天宣布对Elbit Systems Ltd.（NASDAQ: ESLT和TASE: ESLT，简称“Elbit Systems”）旗下医疗技术子公司Beyeonics Vision进行投资。Beyeonics Vision利用一体式增强现实、跟踪和图像处理/人工智能平台，为手术中的外科医生的决策过程提供改进的可视化、优化的工作流程和实时支持。此次合作还促成了Beyeonics™ One在美国…
GEHA Announces 2022 Health and Dental Plan Options and New Plan Perk for Select Offerings
LEE’S SUMMIT, Mo.–(BUSINESS WIRE)–Today, GEHA (pronounced G.E.H.A.) announced its 2022 health and dental plan options available to eligible federal employees through the Federal Employees Health Benefits (FEHB) Program and the Federal Employees Denta…
2021 Report on Proliferative Vitreoretinopathy (Ophthalmology) Drugs In Development – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Proliferative Vitreoretinopathy (PVR) (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Proliferative Vitreoretinopathy (Ophth…
BVIがBeyeonics Visionに対する出資と同社との提携を発表
米マサチューセッツ州ウォルサム–(BUSINESS WIRE)–（ビジネスワイヤ） — 特定の目的をもって設立された多角的・国際的な眼科用機器企業であるBVIは本日、エルビット・システムズ（NASDAQ: ESLT、TASE: ESLT）子会社の医療技術企業Beyeonics Visionへの出資について発表しました。Beyeonics Visionは、統合型の拡張現実、トラッキング、画像処理／AIプラットフォームを使用し、より高度な視覚化能力、最適化されたワークフロー、手術室における外科医の…
Wolfe Eye Clinic to Implement End-to-End Ophthalmology Suite from ModMed®
BOCA RATON, Fla.–(BUSINESS WIRE)–When Wolfe Eye Clinic decided it was time to upgrade the software for its 12 main offices and 9 family vision locations throughout Iowa, they opted to go with ModMed®. Wolfe Eye Clinic also chose to go all in – adopti…
jCyte Announces Appointment of R. Heath Coats as Vice President of CMC, Regulatory Compliance and Quality Control
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced the expansion of the company’s leadership team with the appointment of R. He…
Global 3D Optical Microscope Market 2021-2025, Driven by The Increasing Need for Root Cause Failure Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global 3D Optical Microscope Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. The 3D optical microscope market is poised to grow by $ 96.69 million during 2021-2025, progressing at a CAGR of ov…
Aerie Pharmaceuticals Announces Presentation at the 39th Annual Scientific Meeting of the American Society of Retina Specialists
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company, today announced that topline results from the AR-1105 (dexamethasone intravitreal implant) Phase 2 clinical trial in patients with macular …
BVI gibt Investition und Zusammenarbeit mit Beyeonics Vision bekannt
WALTHAM, Massachusetts (USA)–(BUSINESS WIRE)–BVI, ein zweckgerichtetes, diversifiziertes globales Unternehmen für ophthalmische Geräte, gab heute eine Investition in Beyeonics Vision, eine Medizintechnik-Tochtergesellschaft von Elbit Systems Ltd., (N…
BVI annonce un investissement et une collaboration avec Beyeonics Vision
WALTHAM, Massachusetts–(BUSINESS WIRE)–BVI, une société mondiale diversifiée spécialisée dans les dispositifs ophtalmiques, a annoncé aujourd’hui un investissement dans Beyeonics Vision, une filiale de technologie médicale d’Elbit Systems Ltd. (NASDA…
Global Ocular Drug Delivery System Market Forecast, Trend Analysis & Opportunity Assessment 2021-2031 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Drug Delivery System Market Forecast, Trend Analysis & Opportunity Assessment 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The study offers a global industry analysis for 2016-2020 &…